Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-118 vs Olopatadine in Allergic Conjunctivitis
NCT01657240Phase 3Withdrawn
- Sponsor
- Laboratorios Sophia
- Start
- Nov 2014
- Primary completion
- Apr 2015
01
Overview
A Phase 3 trial of alcaftadine in allergic conjunctivitis (AC), sponsored by Laboratorios Sophia. Planned start Nov 2014; status: withdrawn.
02
Drugs
alcaftadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01657240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657240.